Ignite Creation Date:
2024-05-06 @ 9:23 AM
Last Modification Date:
2024-10-26 @ 12:14 PM
Study NCT ID:
NCT02973737
Status:
UNKNOWN
Last Update Posted:
2022-10-25
First Post:
2016-11-22
Brief Title:
A Study of Pyrotinib Plus Capecitabine in Patients With HER2 Metastatic Breast Cancer
Sponsor:
Jiangsu HengRui Medicine Co Ltd
Organization:
Jiangsu HengRui Medicine Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-07-20
Start Date Type:
ACTUAL
Primary Completion Date:
2023-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-06
Completion Date Type:
ESTIMATED
First Submit Date:
2016-11-22
First Submit QC Date:
November 22 2016
Study First Post Date:
2016-11-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-24
Last Update Post Date:
2022-10-25
Last Update Post Date Type:
ACTUAL